TSMC Briefly Evacuates Some Plants, Suspends Construction After Big Quake in Taiwan — Update
By Kosaku Narioka
Taiwan Semiconductor Manufacturing Co. said it briefly evacuated some plants and suspended work at construction sites following a major earthquake in Taiwan.
A strong earthquake hit eastern Taiwan on Wednesday, triggering tsunami alerts for northern Taiwan and some areas in Japan's Okinawa.
The world's largest contract chip maker said it evacuated some production facilities to ensure the safety of personnel according to company procedure.
Those evacuated in the morning were now beginning to return to their workplaces, it said.
The company was currently confirming details of the impact, it said, adding that its safety systems were operating normally.
TSMC said initial inspections showed that its construction sites were normal, but had decided to suspend work at construction sites for the day and resume them after further inspections.
Write to Kosaku Narioka at kosaku.narioka@wsj.com
(END) Dow Jones Newswires
April 03, 2024 00:26 ET (04:26 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track